CiproDex Ophthalmic Solution: Dual-Action Relief for Eye Infections

Cipro

Cipro

Price from 34.40 $
Product dosage: 250mg
Package (num)Per pillPriceBuy
90$0.38$34.40 (0%)🛒 Add to cart
120$0.32$45.87 $37.84 (17%)🛒 Add to cart
180$0.26$68.80 $46.44 (32%)🛒 Add to cart
360
$0.19 Best per pill
$137.60 $67.94 (51%)🛒 Add to cart
Product dosage: 500mg
Package (num)Per pillPriceBuy
60$0.62$36.98 (0%)🛒 Add to cart
90$0.47$55.47 $42.14 (24%)🛒 Add to cart
120$0.39$73.96 $47.30 (36%)🛒 Add to cart
180$0.32$110.94 $58.48 (47%)🛒 Add to cart
270$0.27$166.41 $73.96 (56%)🛒 Add to cart
360
$0.25 Best per pill
$221.88 $89.44 (60%)🛒 Add to cart
Product dosage: 750mg
Package (num)Per pillPriceBuy
30$1.69$50.74 (0%)🛒 Add to cart
60$1.19$101.48 $71.38 (30%)🛒 Add to cart
90$1.01$152.22 $91.16 (40%)🛒 Add to cart
120$0.93$202.96 $111.80 (45%)🛒 Add to cart
180$0.85$304.44 $152.22 (50%)🛒 Add to cart
360
$0.76 Best per pill
$608.88 $272.62 (55%)🛒 Add to cart
Synonyms

Similar products

CiproDex Ophthalmic Solution is a sterile, combination antimicrobial and anti-inflammatory suspension indicated for the treatment of corneal ulcers and superficial ocular infections, including bacterial conjunctivitis. It combines ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, with dexamethasone, a potent corticosteroid, to effectively eradicate susceptible pathogens while simultaneously controlling the inflammatory response. This dual-mechanism approach not only targets the root bacterial cause but also mitigates associated pain, redness, and swelling, promoting faster clinical resolution and patient comfort. It is a trusted choice among ophthalmologists for cases where both infection and significant inflammation are present.

Features

  • Sterile, preserved ophthalmic suspension in a 5 mL or 10 mL dropper bottle
  • Combination formulation: 0.3% ciprofloxacin (as hydrochloride) and 0.1% dexamethasone
  • Broad-spectrum antibacterial activity against gram-positive and gram-negative organisms
  • Potent anti-inflammatory action to reduce ocular inflammation
  • Isotonic, buffered suspension with benzalkonium chloride 0.006% as preservative
  • pH approximately 5.5; osmolality approximately 300 mOsm/kg

Benefits

  • Rapid eradication of common ocular bacterial pathogens, reducing infection duration
  • Significant reduction in pain, photophobia, redness, and eyelid swelling through anti-inflammatory action
  • Decreased risk of corneal scarring and visual impairment in cases of bacterial corneal ulcers
  • Convenient twice-daily dosing regimen for most indications, enhancing patient compliance
  • Proven clinical efficacy in both pediatric and adult populations (ages 6 months and older)
  • Prevents excessive inflammatory response that can delay healing and cause tissue damage

Common use

CiproDex Ophthalmic Solution is commonly prescribed for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms, including Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa. It is also indicated for the management of corneal ulcers of bacterial origin. Furthermore, it is utilized in cases where postoperative ocular inflammation and infection risk are concurrent concerns, such as following cataract surgery or other intraocular procedures. Its use is appropriate when both an antibacterial and a strong anti-inflammatory agent are deemed necessary by the treating ophthalmologist.

Dosage and direction

For the treatment of bacterial conjunctivitis: Instill 1 or 2 drops into the conjunctival sac of the affected eye(s) every 2 hours while awake for the first 2 days, and then 1 or 2 drops every 4 hours while awake for the next 5 days.

For corneal ulcers: Instill 2 drops into the affected eye every 1 hour while awake and every 2 hours during sleep for the first 2 days. For days 3 through 9, instill 2 drops every 2 hours while awake. From day 10 through treatment completion, instill 2 drops every 4 hours while awake.

Shake the bottle well before each use. To prevent contamination, avoid touching the dropper tip to any surface, including the eye. If more than one ophthalmic product is being used, administer them at least 5 minutes apart.

Precautions

CiproDex Ophthalmic Solution is not intended for injection or use in the ear. Prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated. Use with caution in patients with a history of sensitivity to other quinolones or corticosteroids. As with other antibacterial preparations, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. Patients should be advised not to wear contact lenses if they have signs and symptoms of ocular infection. The preservative benzalkonium chloride may be absorbed by soft contact lenses; patients should remove lenses prior to administration and wait at least 15 minutes before reinsertion.

Contraindications

CiproDex is contraindicated in patients with known hypersensitivity to ciprofloxacin, other quinolones, dexamethasone, or any component of the formulation. It is also contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella. Mycobacterial infection of the eye and fungal diseases of ocular structures are also contraindications. Use is contraindicated after uncomplicated removal of a corneal foreign body.

Possible side effect

The most frequently reported adverse reactions occurring in approximately 1-5% of patients include conjunctival hyperemia, blurred vision, ocular discomfort, white crystalline precipitate (in corneal ulcer patients), foreign body sensation, itching, stinging and burning, corneal staining, and lid edema. Less common reactions (<1%) include corneal infiltrates, nausea, decreased vision, dry eye, eye pain, lid crusting, photophobia, tearing, and allergic reactions. Rarely, ocular surface disease, corneal perforation, and anaphylactic reactions have been reported. Systemic side effects are uncommon but may include headache and taste disturbance.

Drug interaction

Although systemic absorption is low following ocular administration, potential interactions exist. No formal drug interaction studies have been conducted with CiproDex. However, based on the known properties of its components, concomitant use with other corticosteroid-containing products may increase the risk of steroid-related side effects. The concomitant use of other ocular antibiotics is generally not recommended unless specifically directed by a physician. Patients taking systemic anticoagulants should be monitored closely due to potential steroid effects on coagulation parameters.

Missed dose

If a dose is missed, it should be administered as soon as possible. However, if it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining the recommended frequency of administration is important to achieve adequate antibiotic concentrations in the ocular tissues.

Overdose

Ocular overdose may be flushed from the eye(s) with warm tap water. Due to the low systemic absorption, systemic overdose is unlikely following ocular administration. However, if accidentally ingested, symptomatic and supportive care should be provided. Dialysis is not expected to enhance elimination of ciprofloxacin or dexamethasone significantly.

Storage

Store at 2°C to 25°C (36°F to 77°F). Do not freeze. Protect from light. Keep the bottle tightly closed when not in use. Discard the product 28 days after opening the bottle, even if some solution remains, to prevent contamination and reduced efficacy. Keep out of reach of children.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of medical conditions. Do not disregard professional medical advice or delay seeking it because of something you have read here. The prescribing physician should be consulted regarding any questions about the medication.

Reviews

“CiproDex has been a mainstay in my practice for managing moderate to severe bacterial conjunctivitis with significant inflammation. The combination therapy provides rapid symptomatic relief and excellent bacterial eradication rates. I particularly appreciate the reduced treatment duration compared to antibiotic-only regimens.” — Dr. Elena M., Ophthalmologist

“In cases of bacterial corneal ulcers, CiproDex offers the advantage of controlling inflammation while treating the infection. This is critical for preventing scarring and preserving vision. The dosing schedule, while intensive initially, is manageable for motivated patients.” — Dr. Robert T., Corneal Specialist

“Patient compliance with CiproDex is generally good due to the twice-daily maintenance dosing. The most common feedback I receive is rapid reduction in pain and redness within the first 24-48 hours of treatment.” — Dr. Susan L., Comprehensive Ophthalmologist